Page title
Search SAMHSA Publications and Digital Products
Store Facets Summary
- Clear all filters
- Remove Public Health Professionals
- Remove Policymakers
- Remove Resource Guide
- Remove Report
- Remove People with Substance Use or Abuse Problems as Population Group
- Remove People with Alcohol Use or Abuse Problems as Population Group
- Remove Substance Abuse
- Remove Medication-Assisted Treatment
- Remove Crisis Intervention
- Remove Education
- Remove Patient Assessment
- Remove Substance Abuse Screening
Main page content
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
Published: December 2021
This resource provides information to primary care providers and practices on how to implement opioid use disorder treatment using buprenorphine. It identifies common barriers and strategies to overcome them. It documents step-by-step tactics to support buprenorphine implementation.
Telehealth for the Treatment of Serious Mental Illness and Substance Use Disorders
Published: June 2021
This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.
Medicaid Coverage and Financing of Medications to Treat Alcohol and Opioid Use Disorders
Published: November 2014
This report presents information about Medicaid coverage of medication-assisted treatment for opioid and alcohol dependence. It covers treatment effectiveness and cost effectiveness. The report also offers examples of innovative approaches in Vermont, Massachusetts, and Maryland.
Adult Drug Courts and Medication-Assisted Treatment for Opioid Dependence
Published: September 2014
This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.